Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Genopliv ApS
APS
Active
CVR 43711172
Østerled 28A, 2.
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 1,2M
-7% vs 2023
EBITDA margin
24.3%
-54% vs 2023
Equity ratio
49.4%
Financial strength
Net profit 2024
DKK 171K
-65% vs 2023
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
1M
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK 1,2M
-7%
EBITDA
DKK 296K
-54%
Net profit
DKK 171K
-65%
Total assets
DKK 1,3M
+16%
Equity
DKK 663K
+25%
Employees
3
—
Company information
Legal name
Genopliv ApS
CVR number
43711172
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. december 2022
Share capital
DKK 40.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Østerled 28A, 2.
Phone
+4532197129
Email
info@genopliv.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Holbæk
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
1.301
1.214
Staff expenses
-659
-919
EBITDA
643
296
Depreciation & amort.
-0
-50
EBIT
643
246
Net financials
-9
-28
Profit before tax
634
218
Tax
142
47
Net profit
492
171
Balance sheet
DKK thousands
Item
2023
2024
Total assets
1.154
1.341
Equity
532
663
Long-term debt
0
0
Short-term debt
622
679
Total debt
622
679
Financial ratios
5-year trend
EBITDA margin
24.3%
This company
15.8%
Market median
+54% vs market
2023
2024
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
2023
2024
Return on equity
25.8%
This company
18.4%
Market median
+40% vs market
2023
2024
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
2023
2024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
2023
2024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-12-08 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kim Janos Pedersen
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Genopliv ApS also hold positions in
0
other companies.
Person
Role here
Other companies